Menu
  1. Press Room
  2. Press Releases

Press Releases

  • Sep 01, 2020 1:15 PM

    VolitionRx Limited to Present at Conferences in September 2020

  • Aug 13, 2020 9:15 PM

    VolitionRx Limited Announces Second Quarter 2020 Financial Results and Business Update

  • Aug 10, 2020 12:45 PM

    VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update

  • Jul 14, 2020 11:15 AM

    Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test

  • Jun 25, 2020 2:00 PM

    VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes

  • May 27, 2020 2:00 PM

    Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference

  • May 22, 2020 9:15 PM

    VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock

  • May 20, 2020 2:00 PM

    VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock

  • May 13, 2020 10:15 PM

    VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting

  • May 07, 2020 9:15 PM

    VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update

  • May 05, 2020 1:45 PM

    VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update

  • Apr 29, 2020 1:45 PM

    Volition's Nu.Q™ Vet Assay Detects Two Common Canine Cancers

  • Apr 23, 2020 1:45 PM

    Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies

  • Mar 10, 2020 1:00 PM

    VolitionRx Limited Releases Annual Corporate Brochure and Video

  • Mar 03, 2020 1:45 PM

    VolitionRx Limited to Present at Conferences in March 2020

  • Feb 20, 2020 9:15 PM

    VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

  • Feb 18, 2020 9:15 PM

    VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update

  • Feb 18, 2020 1:45 PM

    Volition Unveils Its Epigenetic Toolbox

  • Feb 07, 2020 10:45 PM

    VolitionRx Announces Filing of Registration Statements

  • Jan 13, 2020 2:15 PM

    Volition Develops a New Improved Nu.Q™ Assay Format

  • Jan 10, 2020 1:15 PM

    VolitionRx Completes Acquisition of Octamer GmbH

arrow-downarrow-leftarrow-rightarrowchevron-downcircle-link--redcircle-linkcloseplayplus